MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517018783 A) filed by Mindset Pharma Inc., Toronto, on March 3, for '3-ethylamino-indole dimers as serotonergic agents useful for the treatment of disorders related thereto.'
Inventor(s) include Slassi, Abdelmalik; and Araujo, Joseph A.
The application for the patent was published on April 25, under issue no. 17/2025.
According to the abstract released by the Intellectual Property India: "The present application relates to 3-ethylamino-indole dimers of general Formula I, to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders ...